Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide SR for Diabetes Prevention After Kidney Transplant
NCT03961256Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- May 2019
- Primary completion
- Oct 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Mayo Clinic. Started May 2019; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03961256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961256.